自主通用试剂

Search documents
泰坦科技: 上海泰坦科技股份有限公司2024年年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-12 09:16
Core Viewpoint - The Shanghai Titan Technology Co., Ltd. is preparing for its 2024 Annual General Meeting (AGM) to discuss various proposals, including financial institution credit applications and stock issuance to specific targets, while ensuring shareholder rights and meeting legal requirements [1][2][3]. Group 1: Meeting Procedures - The AGM will verify the identity of attendees and restrict entry to authorized personnel only [2][3]. - Attendees must sign in 30 minutes before the meeting and present necessary identification [2][3]. - The meeting will follow a predetermined agenda for discussing and voting on proposals [2][3][4]. Group 2: Proposals Overview - Proposal 1: Approval of the 2024 Annual Report and its summary [7]. - Proposal 2: Approval of the 2024 Board of Directors' Work Report [9]. - Proposal 3: Approval of the 2024 Supervisory Board's Work Report [10]. - Proposal 4: Approval of the 2024 Financial Settlement Report [11]. - Proposal 5: Approval of the 2024 Profit Distribution Plan, proposing a cash dividend totaling 11,510,588.39 yuan, which is 89.28% of the net profit [11][12]. - Proposal 6: Approval of the 2025 Expected Daily Related Transactions [13][14]. - Proposal 7: Renewal of the accounting firm for the 2025 financial audit [15]. - Proposal 8: Approval of the 2024 Impairment Provision [16][17][18]. - Proposal 9: Approval for the company and its subsidiaries to apply for a total credit limit of up to 4.195 billion yuan from financial institutions [21][22][23]. - Proposal 10: Approval of the 2025 Director Compensation Plan [26]. - Proposal 11: Approval of the 2025 Supervisor Compensation Plan [27]. - Proposal 12: Authorization for the Board to issue stock to specific targets up to 300 million yuan [28]. Group 3: Financial Performance - The company reported a revenue of 288,352.06 million yuan for 2024, a year-on-year increase of 4.11%, while the net profit decreased by 82.23% to 12,892,914.72 yuan due to competitive pricing strategies [29][30]. - The company maintained a stable R&D investment of 15,775.81 million yuan, representing 5.47% of revenue, and filed for 61 new patents [31].